DT
Du Toit Karen
About Du Toit Karen
Data last updated:
Du Toit Karen has 10 years in corporate governance. Holds Director and Non- Individual Subscriber roles. Currently with 2 companies, including Rethink Pharma Private Limited and Mossi Healthcare Private Limited. Formerly with 1 company, such as Stockshift India Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Non- Individual Subscriber | 14 Jul 2026 | 2026 | – | Active | |
| Director | 26 Jul 2023 | 2023 | – | Under Process Of Striking Off |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Feb 2016 | 2016 | ₹2.09 Cr (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Du Toit Karen
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Du Toit Karen
Du Toit Karen has 10 years in corporate governance. Holds Director and Non- Individual Subscriber roles. Currently with 2 companies, including Rethink Pharma Private Limited and Mossi Healthcare Private Limited. Formerly with 1 company, such as Stockshift India Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Du Toit Karen is associated with 2 companies as Director and Non- Individual Subscriber, including Mossi Healthcare Private Limited, Rethink Pharma Private Limited.
Du Toit Karen has expertise in General Business, Healthcare.
Du Toit Karen has 10 years in corporate governance.
Du Toit Karen currently holds positions at 2 companies: Mossi Healthcare Private Limited, Rethink Pharma Private Limited.